Plasma component therapy: new trends.
D000990:Antithrombin III / Q000627:therapeutic use; D020152:Antithrombin III Deficiency; D001779:Blood Coagulation Factors / Q000627:therapeutic use; D001798:Blood Proteins / Q000627:therapeutic use*; D001803:Blood Transfusion; D005353:Fibronectins / Q000627:therapeutic use; D006467:Hemophilia A / Q000628:therapy; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D010949:Plasma; D000515:alpha 1-Antitrypsin / Q000627:therapeutic use
D001779:Blood Coagulation Factors; D001798:Blood Proteins; D005353:Fibronectins; D007074:Immunoglobulin G; D000515:alpha 1-Antitrypsin; C025667:prothrombin complex concentrates; D000990:Antithrombin III